PDIA3 knockout abrogate effects of 1,25(OH)2D3 on cellular respiration and glycolysis in squamous cell carcinoma

Abstract

PDIA3 is an endoplasmic reticulum disulfide isomerase which is involved in the folding and trafficking of newly synthesized proteins. PDIA3 was also described as an alternative receptor for the active form of vitamin D 1,25(OH)2D3. Here, we investigated the impact of PDIA3 in mitochondrial morphology and bioenergetics in squamous cell carcinoma line A431 treated with 1,25(OH)2D3. It was observed that PDIA3 deletion resulted in changes in morphology of mitochondria including a decrease in the percentage of mitochondrial section area, maximal diameter, and perimeter. 1,25(OH)2D3 treatment of A431∆PDIA3 cells partially reversed the effect of PDIA3 deletion increasing aforementioned parameters, while in A431WT cells only an increase in mitochondrial section area was observed. Moreover, PDIA3 knockout affected mitochondrial bioenergetics and modulated STAT3 signaling. Oxygen Consumption Rate (OCR) was significantly increased, with no visible effect of 1,25(OH)2D3 treatment in A431∆PDIA3 cells. In the case of Extracellular Acidification Rate (ECAR) rate an increase was observed for glycolysis and glycolytic capacity parameters in the case of non-treated A431WT cells versus A431∆PDIA3 cells. 1,25(OH)2D3 treatment had no significant effect on glycolytic parameters. Taken together presented results suggests that PDIA3 is strongly involved in the regulation of mitochondrial bioenergetics in cancerous cells and modulation of its response to 1,25(OH)2D3, possibly through STAT3.